(Q61969667)

English

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase I Trial of Vaccination With CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation (English)

0 references

medical condition

multiple myeloma

0 references

sponsor

Memorial Sloan Kettering Cancer Center

0 references

country

United States of America

0 references

start time

31 January 2014

0 references

end time

November 2019

0 references

number of participants

28

0 references

clinical trial phase

phase I clinical trial

0 references

research site

Memorial Sloan Kettering Cancer Center

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01995708

0 references

(Q61969667)

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)